RRM2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.890800E-01
Normal-vs-Stage2
4.360000E-01
Normal-vs-Stage3
8.334100E-02
Normal-vs-Stage4
7.724800E-01
Stage1-vs-Stage2
2.666600E-01
Stage1-vs-Stage3
5.517800E-02
Stage1-vs-Stage4
7.117600E-01
Stage2-vs-Stage3
3.070200E-01
Stage2-vs-Stage4
6.148200E-01
Stage3-vs-Stage4
2.145400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.163800E-01
Normal-vs-AfricanAmerican
7.219400E-01
Normal-vs-Asian
2.444200E-01
Caucasian-vs-AfricanAmerican
8.937200E-01
Caucasian-vs-Asian
3.179200E-01
AfricanAmerican-vs-Asian
4.206000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.179400E-01
Normal-vs-Female
6.426000E-01
Male-vs-Female
5.963400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.416800E-01
Normal-vs-Age(41-60Yrs)
9.234600E-01
Normal-vs-Age(61-80Yrs)
5.510600E-01
Normal-vs-Age(81-100Yrs)
9.285500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.609400E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.771410E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.154800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.656500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.235950E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.386200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.033200E-01
Normal-vs-Daily Drinker
2.392800E-01
Normal-vs-Weekly Drinker
4.081800E-01
Normal-vs-Occasional Drinker
7.895800E-01
Normal-vs-Social Drinker
9.807600E-01
Non Drinker-vs-Daily Drinker
9.880600E-01
Non Drinker-vs-Weekly Drinker
7.493200E-01
Non Drinker-vs-Occasional Drinker
4.646100E-02
Non Drinker-vs-Social Drinker
1.358560E-01
Daily Drinker-vs-Weekly Drinker
7.651200E-01
Daily Drinker-vs-Occasional Drinker
5.052500E-02
Daily Drinker-vs-Social Drinker
1.451770E-01
Weekly Drinker-vs-Occasional Drinker
1.264400E-01
Weekly Drinker-vs-Social Drinker
2.702000E-01
Occasional Drinker-vs-Social Drinker
5.959400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.383590E-01
Normal-vs-Grade 2
2.205600E-02
Normal-vs-Grade 3
5.124000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.777200E-01
Grade 1-vs-Grade 3
5.510600E-01
Grade 1-vs-Grade 4
1.383590E-01
Grade 2-vs-Grade 3
4.185600E-01
Grade 2-vs-Grade 4
2.205600E-02
Grade 3-vs-Grade 4
5.124000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.034800E-01
Normal-vs-NonDiabetic
5.631600E-01
Diabetic-vs-NonDiabetic
7.127800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.964500E-02
Normal-vs-NoPancreatitis
6.294200E-01
Pancreatitis-vs-NoPancreatitis
9.057800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.011200E-01
Normal-vs-N1
4.695200E-01
N0-vs-N1
4.082400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.002000E-01
Normal-vs-TP53-NonMutant
9.393200E-01
TP53-Mutant-vs-TP53-NonMutant
9.940300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
